Jd. Brierley et al., A COMPARISON OF DIFFERENT STAGING SYSTEMS PREDICTABILITY OF PATIENT OUTCOME - THYROID-CARCINOMA AS AN EXAMPLE, Cancer, 79(12), 1997, pp. 2414-2423
BACKGROUND. There is no consensus regarding the comparison of staging
classifications. Recently, numerous staging classifications for thyroi
d carcinoma have been described. This study was performed to evaluate
the relative discriminating ability of these different staging systems
. METHODS. A literature review was conducted to identify the available
staging classifications used for thyroid carcinoma. To compare the va
rious staging classifications, cause specific survival data from a ret
rospective review of 382 patients with papillary and follicular thyroi
d carcinoma treated at Princess Margaret Hospital were applied to the
various staging classifications. The ability of these classifications
to distinguish the stage groupings were compared in the following ways
: 1) tabulating the numbers of patients within each stage group; 2) co
llapsing stage groupings into high and low risk groups and calculating
mortality rates at 10 and 15 years; 3) summing observed deviations at
5, 10, and 15 years; and 4) calculating the proportion of variance ex
plained (PVE) for each staging classification, using each classificati
on separately as a prognostic factor in a Cox regression model. RESULT
S. The application of the PVE model, the only method of the four that
used statistical inference, showed no statistically significant superi
ority of any system over the TNM classification of the American Joint
Committee on Cancer (AJCC) and the International Union Against Cancer
(UICC) in their ability to discriminate stage groupings. CONCLUSIONS.
Because the TNM classification of the AJCC and UICC is universally ava
ilable and widely accepted for other disease sites, the authors recomm
end it for all reports of the treatment and outcome of patients with t
hyroid carcinoma. Individual research groups also may use an alternati
ve, validated classification to report results, provided that the outc
omes are also reported using the TNM classification to facilitate comp
arison between different centers. (C) 1997 American Cancer Society.